APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Anthrax Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Anthrax Vaccines Market Analysis and Forecast 2026-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchVeterinary Anthrax Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Anthrax Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Veterinary Anthrax Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Anthrax Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Anthrax Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Veterinary Anthrax Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Veterinary Anthrax Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Anthrax Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Anthrax Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Anthrax Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Veterinary Anthrax Vaccines include JOVAC, Intervac (PVT) Ltd, Institute for Biological Products, Indian Immunologicals Limited, Empresa Colombiana de Productos Veterinarios S.A, Colorado Serum Company, Ceva Sante Animale, Centro Diagnostico Veterinario and Central Veterinary Control and Research Institute, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Veterinary Anthrax Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Anthrax Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Anthrax Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Anthrax Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Anthrax Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Anthrax Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Veterinary Anthrax Vaccines Segment by Company

JOVAC

Intervac (PVT) Ltd

Institute for Biological Products

Indian Immunologicals Limited

Empresa Colombiana de Productos Veterinarios S.A

Colorado Serum Company

Ceva Sante Animale

Centro Diagnostico Veterinario

Central Veterinary Control and Research Institute

Botswana Vaccine Institute

Biogenesis Bago SA

Bayer Sanidad Animal

Agrovet

Veterinary Anthrax Vaccines Segment by Type

Cell Free PA Vaccines

Live Vaccines

Veterinary Anthrax Vaccines Segment by Application

Cow

Sheep

Swine

Other

Veterinary Anthrax Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Anthrax Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Anthrax Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Anthrax Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Veterinary Anthrax Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Veterinary Anthrax Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Anthrax Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Anthrax Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cell Free PA Vaccines Major Player Table 3. Live Vaccines Major Player Table 4. Global Veterinary Anthrax Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cow Major Player Table 6. Sheep Major Player Table 7. Swine Major Player Table 8. Other Major Player Table 9. Veterinary Anthrax Vaccines Industry Trends Table 10. Veterinary Anthrax Vaccines Industry Drivers Table 11. Veterinary Anthrax Vaccines Industry Opportunities and Challenges Table 12. Veterinary Anthrax Vaccines Industry Restraints Table 13. Global Veterinary Anthrax Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Veterinary Anthrax Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Veterinary Anthrax Vaccines Market Share by Region (2021-2026) Table 16. Global Veterinary Anthrax Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Veterinary Anthrax Vaccines Market Share by Region (2027-2032) Table 18. Global Veterinary Anthrax Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Veterinary Anthrax Vaccines Revenue Market Share by Players (2021-2026) Table 20. Global Veterinary Anthrax Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Veterinary Anthrax Vaccines Key Players Headquarters & Area Served Table 22. Global Veterinary Anthrax Vaccines Players, Product Type & Application Table 23. Global Veterinary Anthrax Vaccines Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Veterinary Anthrax Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Veterinary Anthrax Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Veterinary Anthrax Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Veterinary Anthrax Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2021-2026) Table 30. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2027-2032) Table 31. Global Veterinary Anthrax Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Veterinary Anthrax Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Veterinary Anthrax Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2021-2026) Table 35. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2027-2032) Table 36. JOVAC Company Information Table 37. JOVAC Business Overview Table 38. JOVAC Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. JOVAC Veterinary Anthrax Vaccines Product Portfolio Table 40. JOVAC Recent Development Table 41. Intervac (PVT) Ltd Company Information Table 42. Intervac (PVT) Ltd Business Overview Table 43. Intervac (PVT) Ltd Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product Portfolio Table 45. Intervac (PVT) Ltd Recent Development Table 46. Institute for Biological Products Company Information Table 47. Institute for Biological Products Business Overview Table 48. Institute for Biological Products Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Institute for Biological Products Veterinary Anthrax Vaccines Product Portfolio Table 50. Institute for Biological Products Recent Development Table 51. Indian Immunologicals Limited Company Information Table 52. Indian Immunologicals Limited Business Overview Table 53. Indian Immunologicals Limited Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Portfolio Table 55. Indian Immunologicals Limited Recent Development Table 56. Empresa Colombiana de Productos Veterinarios S.A Company Information Table 57. Empresa Colombiana de Productos Veterinarios S.A Business Overview Table 58. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Portfolio Table 60. Empresa Colombiana de Productos Veterinarios S.A Recent Development Table 61. Colorado Serum Company Company Information Table 62. Colorado Serum Company Business Overview Table 63. Colorado Serum Company Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Colorado Serum Company Veterinary Anthrax Vaccines Product Portfolio Table 65. Colorado Serum Company Recent Development Table 66. Ceva Sante Animale Company Information Table 67. Ceva Sante Animale Business Overview Table 68. Ceva Sante Animale Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Ceva Sante Animale Veterinary Anthrax Vaccines Product Portfolio Table 70. Ceva Sante Animale Recent Development Table 71. Centro Diagnostico Veterinario Company Information Table 72. Centro Diagnostico Veterinario Business Overview Table 73. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Portfolio Table 75. Centro Diagnostico Veterinario Recent Development Table 76. Central Veterinary Control and Research Institute Company Information Table 77. Central Veterinary Control and Research Institute Business Overview Table 78. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Portfolio Table 80. Central Veterinary Control and Research Institute Recent Development Table 81. Botswana Vaccine Institute Company Information Table 82. Botswana Vaccine Institute Business Overview Table 83. Botswana Vaccine Institute Veterinary Anthrax Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Portfolio Table 85. Botswana Vaccine Institute Recent Development Table 86. Biogenesis Bago SA Company Information Table 87. Biogenesis Bago SA Business Overview Table 88. Biogenesis Bago SA Veterinary Anthrax Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Biogenesis Bago SA Veterinary Anthrax Vaccines Product Portfolio Table 90. Biogenesis Bago SA Recent Development Table 91. Bayer Sanidad Animal Company Information Table 92. Bayer Sanidad Animal Business Overview Table 93. Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Portfolio Table 95. Bayer Sanidad Animal Recent Development Table 96. Agrovet Company Information Table 97. Agrovet Business Overview Table 98. Agrovet Veterinary Anthrax Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Agrovet Veterinary Anthrax Vaccines Product Portfolio Table 100. Agrovet Recent Development Table 101. North America Veterinary Anthrax Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Veterinary Anthrax Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Veterinary Anthrax Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Veterinary Anthrax Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Veterinary Anthrax Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Veterinary Anthrax Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Veterinary Anthrax Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Veterinary Anthrax Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Veterinary Anthrax Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Veterinary Anthrax Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Veterinary Anthrax Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Veterinary Anthrax Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 115. China Veterinary Anthrax Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 116. China Veterinary Anthrax Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 117. China Veterinary Anthrax Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 118. China Veterinary Anthrax Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Veterinary Anthrax Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Veterinary Anthrax Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Veterinary Anthrax Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Veterinary Anthrax Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Veterinary Anthrax Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Veterinary Anthrax Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Veterinary Anthrax Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Veterinary Anthrax Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Veterinary Anthrax Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Veterinary Anthrax Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Veterinary Anthrax Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Veterinary Anthrax Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Veterinary Anthrax Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Veterinary Anthrax Vaccines Image Figure 2. Global Veterinary Anthrax Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Anthrax Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cell Free PA Vaccines Image Figure 5. Live Vaccines Image Figure 6. Global Veterinary Anthrax Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Veterinary Anthrax Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cow Image Figure 9. Sheep Image Figure 10. Swine Image Figure 11. Other Image Figure 12. Global Veterinary Anthrax Vaccines Market Size (US$ Million) & (2021-2032) Figure 13. Global Veterinary Anthrax Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Veterinary Anthrax Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Anthrax Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Veterinary Anthrax Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Veterinary Anthrax Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2021-2032) Figure 20. Global Veterinary Anthrax Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2021-2032) Figure 23. North America Veterinary Anthrax Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032) Figure 25. North America Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032) Figure 26. North America Veterinary Anthrax Vaccines Revenue Share by Country (2021-2032) Figure 27. United States Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Veterinary Anthrax Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032) Figure 32. Europe Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032) Figure 33. Europe Veterinary Anthrax Vaccines Revenue Share by Country (2021-2032) Figure 34. Germany Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Veterinary Anthrax Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032) Figure 44. China Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032) Figure 45. Asia Veterinary Anthrax Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032) Figure 47. Asia Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032) Figure 48. Asia Veterinary Anthrax Vaccines Revenue Share by Region (2021-2032) Figure 49. Japan Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Veterinary Anthrax Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032) Figure 57. SAMEA Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032) Figure 58. SAMEA Veterinary Anthrax Vaccines Revenue Share by Country (2021-2032) Figure 59. Brazil Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Veterinary Anthrax Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Free PA Vaccines
  • Live Vaccines
Applications
  • Cow
  • Sheep
  • Swine
  • Other
Companies covered
  • JOVAC
  • Intervac (PVT) Ltd
  • Institute for Biological Products
  • Indian Immunologicals Limited
  • Empresa Colombiana de Productos Veterinarios S.A
  • Colorado Serum Company
  • Ceva Sante Animale
  • Centro Diagnostico Veterinario
  • Central Veterinary Control and Research Institute
  • Botswana Vaccine Institute
  • Biogenesis Bago SA
  • Bayer Sanidad Animal
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Anthrax Vaccines Market by Type
  3. 1.2.1 Global Veterinary Anthrax Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cell Free PA Vaccines
  5. 1.2.3 Live Vaccines
  6. 1.3 Veterinary Anthrax Vaccines Market by Application
  7. 1.3.1 Global Veterinary Anthrax Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cow
  9. 1.3.3 Sheep
  10. 1.3.4 Swine
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Veterinary Anthrax Vaccines Market Dynamics
  1. 2.1 Veterinary Anthrax Vaccines Industry Trends
  2. 2.2 Veterinary Anthrax Vaccines Industry Drivers
  3. 2.3 Veterinary Anthrax Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary Anthrax Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Veterinary Anthrax Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Veterinary Anthrax Vaccines Growth Trends by Region
  3. 3.2.1 Global Veterinary Anthrax Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Anthrax Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Veterinary Anthrax Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Veterinary Anthrax Vaccines Revenue by Players
  2. 4.1.1 Global Veterinary Anthrax Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Veterinary Anthrax Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Veterinary Anthrax Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Anthrax Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Veterinary Anthrax Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Veterinary Anthrax Vaccines Players, Product Type & Application
  8. 4.5 Global Veterinary Anthrax Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Veterinary Anthrax Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Veterinary Anthrax Vaccines Tier 1, Tier 2, and Tier 3
5 Veterinary Anthrax Vaccines Market Size by Type
  1. 5.1 Global Veterinary Anthrax Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Veterinary Anthrax Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2021-2032)
6 Veterinary Anthrax Vaccines Market Size by Application
  1. 6.1 Global Veterinary Anthrax Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Veterinary Anthrax Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 JOVAC
  2. 7.1.1 JOVAC Company Information
  3. 7.1.2 JOVAC Business Overview
  4. 7.1.3 JOVAC Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 JOVAC Veterinary Anthrax Vaccines Product Portfolio
  6. 7.1.5 JOVAC Recent Developments
  7. 7.2 Intervac (PVT) Ltd
  8. 7.2.1 Intervac (PVT) Ltd Company Information
  9. 7.2.2 Intervac (PVT) Ltd Business Overview
  10. 7.2.3 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Intervac (PVT) Ltd Veterinary Anthrax Vaccines Product Portfolio
  12. 7.2.5 Intervac (PVT) Ltd Recent Developments
  13. 7.3 Institute for Biological Products
  14. 7.3.1 Institute for Biological Products Company Information
  15. 7.3.2 Institute for Biological Products Business Overview
  16. 7.3.3 Institute for Biological Products Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Institute for Biological Products Veterinary Anthrax Vaccines Product Portfolio
  18. 7.3.5 Institute for Biological Products Recent Developments
  19. 7.4 Indian Immunologicals Limited
  20. 7.4.1 Indian Immunologicals Limited Company Information
  21. 7.4.2 Indian Immunologicals Limited Business Overview
  22. 7.4.3 Indian Immunologicals Limited Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Portfolio
  24. 7.4.5 Indian Immunologicals Limited Recent Developments
  25. 7.5 Empresa Colombiana de Productos Veterinarios S.A
  26. 7.5.1 Empresa Colombiana de Productos Veterinarios S.A Company Information
  27. 7.5.2 Empresa Colombiana de Productos Veterinarios S.A Business Overview
  28. 7.5.3 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Portfolio
  30. 7.5.5 Empresa Colombiana de Productos Veterinarios S.A Recent Developments
  31. 7.6 Colorado Serum Company
  32. 7.6.1 Colorado Serum Company Company Information
  33. 7.6.2 Colorado Serum Company Business Overview
  34. 7.6.3 Colorado Serum Company Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Colorado Serum Company Veterinary Anthrax Vaccines Product Portfolio
  36. 7.6.5 Colorado Serum Company Recent Developments
  37. 7.7 Ceva Sante Animale
  38. 7.7.1 Ceva Sante Animale Company Information
  39. 7.7.2 Ceva Sante Animale Business Overview
  40. 7.7.3 Ceva Sante Animale Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Ceva Sante Animale Veterinary Anthrax Vaccines Product Portfolio
  42. 7.7.5 Ceva Sante Animale Recent Developments
  43. 7.8 Centro Diagnostico Veterinario
  44. 7.8.1 Centro Diagnostico Veterinario Company Information
  45. 7.8.2 Centro Diagnostico Veterinario Business Overview
  46. 7.8.3 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Portfolio
  48. 7.8.5 Centro Diagnostico Veterinario Recent Developments
  49. 7.9 Central Veterinary Control and Research Institute
  50. 7.9.1 Central Veterinary Control and Research Institute Company Information
  51. 7.9.2 Central Veterinary Control and Research Institute Business Overview
  52. 7.9.3 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Portfolio
  54. 7.9.5 Central Veterinary Control and Research Institute Recent Developments
  55. 7.10 Botswana Vaccine Institute
  56. 7.10.1 Botswana Vaccine Institute Company Information
  57. 7.10.2 Botswana Vaccine Institute Business Overview
  58. 7.10.3 Botswana Vaccine Institute Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Portfolio
  60. 7.10.5 Botswana Vaccine Institute Recent Developments
  61. 7.11 Biogenesis Bago SA
  62. 7.11.1 Biogenesis Bago SA Company Information
  63. 7.11.2 Biogenesis Bago SA Business Overview
  64. 7.11.3 Biogenesis Bago SA Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Biogenesis Bago SA Veterinary Anthrax Vaccines Product Portfolio
  66. 7.11.5 Biogenesis Bago SA Recent Developments
  67. 7.12 Bayer Sanidad Animal
  68. 7.12.1 Bayer Sanidad Animal Company Information
  69. 7.12.2 Bayer Sanidad Animal Business Overview
  70. 7.12.3 Bayer Sanidad Animal Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Portfolio
  72. 7.12.5 Bayer Sanidad Animal Recent Developments
  73. 7.13 Agrovet
  74. 7.13.1 Agrovet Company Information
  75. 7.13.2 Agrovet Business Overview
  76. 7.13.3 Agrovet Veterinary Anthrax Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Agrovet Veterinary Anthrax Vaccines Product Portfolio
  78. 7.13.5 Agrovet Recent Developments
8 North America
  1. 8.1 North America Veterinary Anthrax Vaccines Revenue (2021-2032)
  2. 8.2 North America Veterinary Anthrax Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Veterinary Anthrax Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Veterinary Anthrax Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Veterinary Anthrax Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Veterinary Anthrax Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Veterinary Anthrax Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Veterinary Anthrax Vaccines Revenue by Country
  11. 8.6.1 North America Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Veterinary Anthrax Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Veterinary Anthrax Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Veterinary Anthrax Vaccines Revenue (2021-2032)
  2. 9.2 Europe Veterinary Anthrax Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Veterinary Anthrax Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Veterinary Anthrax Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Veterinary Anthrax Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Veterinary Anthrax Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Veterinary Anthrax Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Veterinary Anthrax Vaccines Revenue by Country
  11. 9.6.1 Europe Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Veterinary Anthrax Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Veterinary Anthrax Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Veterinary Anthrax Vaccines Revenue (2021-2032)
  2. 10.2 China Veterinary Anthrax Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Veterinary Anthrax Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Veterinary Anthrax Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Veterinary Anthrax Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Veterinary Anthrax Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Veterinary Anthrax Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Anthrax Vaccines Revenue (2021-2032)
  2. 11.2 Asia Veterinary Anthrax Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Veterinary Anthrax Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Veterinary Anthrax Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Veterinary Anthrax Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Veterinary Anthrax Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Veterinary Anthrax Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Veterinary Anthrax Vaccines Revenue by Country
  11. 11.6.1 Asia Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Veterinary Anthrax Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Veterinary Anthrax Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Anthrax Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Veterinary Anthrax Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Veterinary Anthrax Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Veterinary Anthrax Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Veterinary Anthrax Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Veterinary Anthrax Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Veterinary Anthrax Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Veterinary Anthrax Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Veterinary Anthrax Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Veterinary Anthrax Vaccines Revenue by Country
  11. 12.6.1 SAMEA Veterinary Anthrax Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Veterinary Anthrax Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Veterinary Anthrax Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst